APA

Davies K. D., Humphries M. J., Sullivan F. X., von Carlowitz I., Le Huerou Y., Mohr P. J., Wang B., Blake J. F., Lyon M. A., Gunawardana I., Chicarelli M., Wallace E. & Gross S. (20111006). Single-agent inhibition of Chk1 is antiproliferative in human cancer cell lines in vitro and inhibits tumor xenograft growth in vivo. : Oncology research.

Chicago

Davies Kurtis D, Humphries Michael J, Sullivan Francis X, von Carlowitz Ira, Le Huerou Yvan, Mohr Peter J, Wang Bin, Blake James F, Lyon Michael A, Gunawardana Indrani, Chicarelli Mark, Wallace Eli and Gross Stefan. 20111006. Single-agent inhibition of Chk1 is antiproliferative in human cancer cell lines in vitro and inhibits tumor xenograft growth in vivo. : Oncology research.

Harvard

Davies K. D., Humphries M. J., Sullivan F. X., von Carlowitz I., Le Huerou Y., Mohr P. J., Wang B., Blake J. F., Lyon M. A., Gunawardana I., Chicarelli M., Wallace E. and Gross S. (20111006). Single-agent inhibition of Chk1 is antiproliferative in human cancer cell lines in vitro and inhibits tumor xenograft growth in vivo. : Oncology research.

MLA

Davies Kurtis D, Humphries Michael J, Sullivan Francis X, von Carlowitz Ira, Le Huerou Yvan, Mohr Peter J, Wang Bin, Blake James F, Lyon Michael A, Gunawardana Indrani, Chicarelli Mark, Wallace Eli and Gross Stefan. Single-agent inhibition of Chk1 is antiproliferative in human cancer cell lines in vitro and inhibits tumor xenograft growth in vivo. : Oncology research. 20111006.